Atmobiosciences
New York City, US · 1 known investors
Find your way into Atmobiosciences
Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.
Founders & leadership
MH
Mal HebblewhiteCEO
Investors · 1
Frequently asked questions
- What does Atmobiosciences do?
- Atmo Biosciences develops an FDA-cleared ingestible capsule using gas-sensing technology to diagnose gastrointestinal dysmotility conditions for gastroenterologists. The product provides objective clinical data to help manage treatment decisions and side effects in patients, particularly those experiencing gastrointestinal complications from GLP-1 weight loss medications.
- Who are Atmobiosciences's investors?
- Atmobiosciences's investors include Breakthrough Victoria.
- Where is Atmobiosciences headquartered?
- Atmobiosciences is headquartered in New York City, US.